Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc V.CUR


Primary Symbol: DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by Betteryear2on Apr 11, 2022 9:26am
113 Views
Post# 34593191

Consolidated Uranium Initiates Exploration Program

Consolidated Uranium Initiates Exploration Program TORONTO, April 11, 2022 (GLOBE NEWSWIRE) -- Consolidated Uranium Inc. (“CUR”, the “Company”, “Consolidated Uranium”) (TSXV: CUR) (OTCQB: CURUF) is pleased to provide details of a planned work program at its 100% owned Laguna Salada Uranium-Vanadium Project (“Laguna Salada” or the “Project”) located in Chubut Province, Argentina (Figure 1).

Consolidated Uranium Initiates Exploration Program Targeting Higher Grade Uranium Mineralization at Laguna Salada in Argentina
 
 
<< Previous
Bullboard Posts
Next >>